Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes”
Pure Extracts trading on CSE under “PULL” symbol Pure Extracts cannabis and hemp industry verticals include toll processing, white labeling and developing its own private label of cannabis products Pure Extracts is entering the functional mushroom market Company’s CO2 extraction facility complies with European Union GMP standards – intends to seek EU GMP certification for … Continue reading “Pure Extracts Technologies Corp. (CSE: PULL) Now Trading on the Canadian Securities Exchange Under “PULL” Symbol”
NetworkNewsWire Editorial Coverage: Drug development means big money these days as big pharma and life science companies work to discover treatments that make a difference in the world. Investors are showing strong interest in the drug-development industry, and savvy companies are also making strategic M&A moves to strengthen their positions in the growing space. Life … Continue reading “Savvy Companies Making Moves in Drug-Development Space”
NetworkNewsWire Editorial Coverage: Big pharma and life science companies are making big news these days. The drug-development space is seeing strong investor interest as these companies make breakthrough advancements that address vast unmet medical needs. Strategic M&A moves are adding spice to the gumbo for investors as pioneering research remains focused on providing life-changing treatments … Continue reading “On the Trail of Better Therapeutics for Depression”
Pure Extracts, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://nnw.fm/vwI8u). Studied extensively for their various health benefits, current research suggests different … Continue reading “NetworkNewsBreaks – Pure Extracts Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’”
Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has provided an update on its efforts to resolve a continuous disclosure review that was issued earlier this year. Champignon is working closely with the British Columbia Securities Commission (“BCSC”) to coordinate the revocation of the cease trade order and hopes to provide information about a revocation of … Continue reading “NetworkNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Addresses Continuous Disclosure Review”
Research indicates that functional and medicinal mushrooms offer range of physical and mental benefits Pure Extracts’ milestone-based strategy catalyzing Company growth Strategy includes license procurement, production, marketing of in-house and white label products Mainstream science is now catching up with what traditional medicine has known for years — that functional and medicinal mushrooms can help … Continue reading “Medicinal Mushrooms Booming, Pure Extract Technologies Inc. First-Mover Strategy Catalyzing Growth”
Scientific research suggests some mushrooms can provide mental benefits, anti-tumor effects, improved immune function, anti-viral properties and detoxification “Psychedelic” varieties currently being studied for depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease, addiction Pure Extracts is expanding into functional mushroom market; Company is currently licensed by Health Canada to buy, sell, produce cannabis products Mushrooms have … Continue reading “Pure Extract Technologies Inc. Leveraging Growing Popularity of Medicinal Mushrooms in Mainstream Medicine”
NetworkNewsWire Editorial Coverage: Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as “magic mushrooms.” There is new hope for treating such debilitating disorders … Continue reading “Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics”
Pure Extract Technologies, a private, plant-based extraction company, is positioning for opportunity amid the ramping up of next-generation research regarding potential benefits of functional mushrooms and psilocybin compounds. The company is pursuing a Natural Health Products Site License from Health Canada to buy, sell and produce functional mushroom products in an EU-GMP-compliant environment. This will … Continue reading “NetworkNewsBreaks – Pure Extract Technologies Inc. Positioning as Research Looks to the ‘Magic’ in Mushrooms”
